{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Méglutol : Questions médicales les plus fréquentes",
"headline": "Méglutol : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Méglutol : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-12",
"dateModified": "2025-03-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Méglutol"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glutarates",
"url": "https://questionsmedicales.fr/mesh/D005977",
"about": {
"@type": "MedicalCondition",
"name": "Glutarates",
"code": {
"@type": "MedicalCode",
"code": "D005977",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.241.081.337.351"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Méglutol",
"alternateName": "Meglutol",
"code": {
"@type": "MedicalCode",
"code": "D015093",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Marvin N Iman",
"url": "https://questionsmedicales.fr/author/Marvin%20N%20Iman",
"affiliation": {
"@type": "Organization",
"name": "Department of Biotechnology, Graduate School of Engineering, Osaka University, Japan."
}
},
{
"@type": "Person",
"name": "Danielle E Haslam",
"url": "https://questionsmedicales.fr/author/Danielle%20E%20Haslam",
"affiliation": {
"@type": "Organization",
"name": "Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Liming Liang",
"url": "https://questionsmedicales.fr/author/Liming%20Liang",
"affiliation": {
"@type": "Organization",
"name": "Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA."
}
},
{
"@type": "Person",
"name": "Kai Guo",
"url": "https://questionsmedicales.fr/author/Kai%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Center for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, Puerto Rico, USA."
}
},
{
"@type": "Person",
"name": "Kaumudi Joshipura",
"url": "https://questionsmedicales.fr/author/Kaumudi%20Joshipura",
"affiliation": {
"@type": "Organization",
"name": "Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Center for Clinical Research and Health Promotion, Graduate School of Public Health, University of Puerto Rico Medical Sciences Campus, Puerto Rico, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Post-prostatic-massage urine exosomes of men with chronic prostatitis/chronic pelvic pain syndrome carry prostate-cancer-typical microRNAs and activate proto-oncogenes.",
"datePublished": "2022-11-17",
"url": "https://questionsmedicales.fr/article/36321189",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/1878-0261.13329"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effects of low-intensity pulsed ultrasound on the microorganisms of expressed prostatic secretion in patients with IIIB prostatitis.",
"datePublished": "2024-07-04",
"url": "https://questionsmedicales.fr/article/38965410",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-66329-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Preclinical models and evaluation criteria of prostatitis.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37228599",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1183895"
}
},
{
"@type": "ScholarlyArticle",
"name": "Chronic prostatitis as possible risk factor for Peyronie's disease: Psychological, sexual and prostatitis-like symptoms in patients with PD.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37259816",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.4081/aiua.2023.11406"
}
},
{
"@type": "ScholarlyArticle",
"name": "How I manage bacterial prostatitis.",
"datePublished": "2022-06-13",
"url": "https://questionsmedicales.fr/article/35709903",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cmi.2022.05.035"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides carboxyliques",
"item": "https://questionsmedicales.fr/mesh/D002264"
},
{
"@type": "ListItem",
"position": 4,
"name": "Acides acycliques",
"item": "https://questionsmedicales.fr/mesh/D000144"
},
{
"@type": "ListItem",
"position": 5,
"name": "Diacides carboxyliques",
"item": "https://questionsmedicales.fr/mesh/D003998"
},
{
"@type": "ListItem",
"position": 6,
"name": "Glutarates",
"item": "https://questionsmedicales.fr/mesh/D005977"
},
{
"@type": "ListItem",
"position": 7,
"name": "Méglutol",
"item": "https://questionsmedicales.fr/mesh/D015093"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Méglutol - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Méglutol",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Méglutol",
"description": "Comment diagnostiquer un besoin de Méglutol ?\nQuels tests sont utilisés pour le diabète ?\nQuand envisager le Méglutol ?\nQuels signes indiquent un diabète avancé ?\nLe Méglutol est-il prescrit pour tous les diabétiques ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Prostatitis&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Méglutol",
"description": "Quels symptômes le Méglutol aide-t-il à réduire ?\nLe Méglutol provoque-t-il des effets secondaires ?\nComment reconnaître une hypoglycémie ?\nLe Méglutol affecte-t-il le poids ?\nQuels sont les signes d'une réaction allergique ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Prostatitis&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Méglutol",
"description": "Comment prévenir le diabète de type 2 ?\nLe Méglutol peut-il être utilisé préventivement ?\nQuels modes de vie favorisent la santé métabolique ?\nLes contrôles réguliers de la glycémie sont-ils importants ?\nComment le stress influence-t-il le diabète ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Prostatitis&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Méglutol",
"description": "Comment le Méglutol est-il administré ?\nPeut-on combiner le Méglutol avec d'autres médicaments ?\nQuelle est la posologie habituelle du Méglutol ?\nLe Méglutol nécessite-t-il un suivi médical ?\nQuels sont les objectifs du traitement avec Méglutol ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Prostatitis&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Méglutol",
"description": "Quelles sont les complications du diabète non contrôlé ?\nLe Méglutol réduit-il les risques de complications ?\nComment prévenir les complications du diabète ?\nLes complications peuvent-elles être réversibles ?\nQuels examens sont nécessaires pour détecter les complications ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Prostatitis&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Méglutol",
"description": "Quels sont les principaux facteurs de risque du diabète ?\nLe stress est-il un facteur de risque ?\nL'alimentation influence-t-elle le risque de diabète ?\nL'âge est-il un facteur de risque pour le diabète ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D015093?mesh_terms=Prostatitis&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un besoin de Méglutol ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic de diabète de type 2 est établi par des tests de glycémie et d'insuline."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diabète ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la glycémie à jeun, l'HbA1c et le test de tolérance au glucose."
}
},
{
"@type": "Question",
"name": "Quand envisager le Méglutol ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est envisagé lorsque les changements de mode de vie ne suffisent pas à contrôler la glycémie."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un diabète avancé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent une soif excessive, des mictions fréquentes et une fatigue persistante."
}
},
{
"@type": "Question",
"name": "Le Méglutol est-il prescrit pour tous les diabétiques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est principalement prescrit pour les patients avec un diabète de type 2 non contrôlé."
}
},
{
"@type": "Question",
"name": "Quels symptômes le Méglutol aide-t-il à réduire ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il aide à réduire les symptômes liés à l'hyperglycémie, comme la soif et la fatigue."
}
},
{
"@type": "Question",
"name": "Le Méglutol provoque-t-il des effets secondaires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires peuvent inclure des nausées, des diarrhées et des douleurs abdominales."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une hypoglycémie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des sueurs, des tremblements, de la confusion et une faim intense."
}
},
{
"@type": "Question",
"name": "Le Méglutol affecte-t-il le poids ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut entraîner une légère perte de poids chez certains patients, mais pas chez tous."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une réaction allergique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des éruptions cutanées, des démangeaisons et un gonflement du visage."
}
},
{
"@type": "Question",
"name": "Comment prévenir le diabète de type 2 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et le maintien d'un poids santé sont essentiels."
}
},
{
"@type": "Question",
"name": "Le Méglutol peut-il être utilisé préventivement ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il est utilisé pour traiter le diabète déjà établi, pas pour la prévention."
}
},
{
"@type": "Question",
"name": "Quels modes de vie favorisent la santé métabolique ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une activité physique régulière, une alimentation riche en fibres et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Les contrôles réguliers de la glycémie sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à détecter les anomalies précocement et à ajuster le traitement si nécessaire."
}
},
{
"@type": "Question",
"name": "Comment le stress influence-t-il le diabète ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress peut augmenter la glycémie, rendant le contrôle du diabète plus difficile."
}
},
{
"@type": "Question",
"name": "Comment le Méglutol est-il administré ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est généralement pris par voie orale, souvent avant les repas pour maximiser son efficacité."
}
},
{
"@type": "Question",
"name": "Peut-on combiner le Méglutol avec d'autres médicaments ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut être combiné avec d'autres antidiabétiques pour un meilleur contrôle glycémique."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie habituelle du Méglutol ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie, mais commence souvent à 0,5 mg à 1 mg par jour, ajustée selon les besoins."
}
},
{
"@type": "Question",
"name": "Le Méglutol nécessite-t-il un suivi médical ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour ajuster le traitement et surveiller les effets."
}
},
{
"@type": "Question",
"name": "Quels sont les objectifs du traitement avec Méglutol ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'objectif est de maintenir une glycémie normale et de prévenir les complications du diabète."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du diabète non contrôlé ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des maladies cardiovasculaires, des neuropathies et des problèmes rénaux."
}
},
{
"@type": "Question",
"name": "Le Méglutol réduit-il les risques de complications ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon contrôle glycémique avec Méglutol peut réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications du diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier, une bonne hygiène de vie et un contrôle glycémique strict sont essentiels."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et un bon contrôle."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour détecter les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers des yeux, des reins et des pieds sont recommandés pour détecter les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du diabète ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'obésité, l'inactivité physique, l'âge et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à l'augmentation de la glycémie et au diabète."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de diabète ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en sucres et en graisses augmente le risque de diabète de type 2."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque pour le diabète ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de diabète augmente avec l'âge, surtout après 45 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des membres de la famille atteints de diabète augmente le risque personnel."
}
}
]
}
]
}
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) has a high prevalence of up to 15% and accounts for 90-95% of prostatitis diagnoses, and yet its etiopathogenesis and link to prostate cancer...
To detect and analyze the changes of microorganisms in expressed prostatic secretion (EPS) of patients with IIIB prostatitis before and after low-intensity pulsed ultrasound (LIPUS) treatment, and to ...
Prostatitis is a common urological condition that affects almost half of all men at some point in their life. The prostate gland has a dense nerve supply that contributes to the production of fluid to...
This study aims to investigate a possible relationship between chronic prostatitis (CP) and Peyronie's disease (PD) and to characterize the psychological profile of patients suffering from PD, with or...
We included 539 patients with PD, of which 200 were found to have underlying CP. As a comparator population, we selected 2201 patients without PD, referring to our tertiary care clinic. In this popula...
The overall prevalence of chronic prostatitis in PD patients was 37.1% compared to a prevalence of 17.4% in the non-PD control population (OR = 2.79 and p < 0.0001). The severity of CP symptom total s...
Chronic prostatitis (CP) and Peyronie's disease (PD) are frequently associated. Our results demonstrate the strong impact of chronic prostatitis on the mental status of PD patients. Anxiety and depres...
Bacterial prostatitis is a highly prevalent infection responsible for significant morbidity among men. The diagnosis and treatment for bacterial prostatitis remains complicated. The difficulty in diag...
We aimed to provide a useful resource for clinicians in effectively diagnosing and managing acute bacterial prostatitis (ABP) and chronic bacterial prostatitis (CBP)....
A PubMed literature search on prostatitis was performed with no restrictions on publication date....
The epidemiology, pathophysiology, diagnosis, and treatment for ABP and CBP are explored using a clinical vignette as relevant context....
Bacterial prostatitis can be diagnosed through a focused history and microbiological investigations. The Meares-Stamey 4-glass test or modified 2-glass test can help confirm the diagnosis if uncertain...
Bacterial prostatitis, acute or chronic, is one of the most prevalent urogenital infections in men. Its diagnosis requires the application of a careful methodology. Gram-negative bacilli are the most ...
The aim of this article is to summarize the current evidence regarding the pathogenesis, etiology, empirical and definitive antimicrobial therapy, and new pharmacotherapeutic interventions to improve ...
Bacterial prostatitis requires the application of an accurate diagnostic protocol to identify the causative agent and establish the optimal antimicrobial treatment. The structural and biochemical char...
To evaluate the relation between resistive index (RI) of prostatic capsular arteries by transrectal Doppler ultrasonography in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and its correl...
In total, we included 68 patients presenting with chronic prostatitis/chronic pelvic pain syndrome. We formed two groups, as Group 1 of 35 patients with a RI ≥ 0.7 and Group 2 of 33 patients with RI <...
Demographic characteristics were similar in the two groups. IPSS was 11.3 ± 6 in Group 1 and 9.7 ± 5.3 in Group 2. IIEF-5 was 18.6 ± 2 in Group 1 and 20.4 ± 2.3 in Group 2. PEDT was 12.4 ± 5.6 in Grou...
There is a significant correlation between the lower urinary tract symptoms and erectile dysfunction parameters and the RI of the prostatic capsular artery in CP/CPPS and RI is an effective and noninv...
Single-cell RNA sequencing studies in the human prostate have defined a population of epithelial cells with transcriptional similarities to club cells in the lung. However, the localization of club-li...
Benign prostate hyperplasia (BPH) is a common cause for bladder outlet obstruction (BOO) and lower urinary tract symptoms (LUTS) in men. The pathophysiology of BPH is multifactorial and inflammation h...
Patients who had undergone TURP for BPH at a single institution between 2014 and 2018 were included. The study population was divided into three cohorts: those with no histological inflammation, those...
A total 198 patients were included (no inflammation n = 101; any inflammation n = 97, prostatic stromal inflammation n = 81). All three groups were comparable in terms of baseline characteristics. The...
Histological prostatitis is associated with worse urinary outcomes after TURP compared to no inflammation. These results are useful in improving prognostic discussions with patients after TURP....
The expression of programmed cell death ligand protein (PD-L1) is weakly investigated in non-tumoral and inflammatory prostatic pathology. The diagnosis of granulomatous prostatitis (GP) rests on the ...
We studied PD-L1 expression in 17 GP cases (9 nonspecific GP, 5 Bacillus Calmette-Guérin induced prostatitis, 1 prostatic tuberculosis, and 3 cases of postsurgical prostatic granulomas). The control g...
All of the GP cases showed easily visible strong membranous PD-L1 expression (high levels of combined positive score) in localized and diffuse epithelioid granulomatous prostatic inflammation. None of...
The study presents the first attempt to examine PD-L1 expression in GP. Granulomatous inflammation in GP is easily identified when stained with PD-L1....